These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 12858459)
1. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis. De Ceuninck F; Sabatini M; Renoux V; de Nanteuil G; Pastoureau P J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459 [TBL] [Abstract][Full Text] [Related]
2. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments. Ishikawa T; Nishigaki F; Christgau S; Noto T; Mo J; From N; Minoura K; Hirayama Y; Ohkubo Y; Mutoh S J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932 [TBL] [Abstract][Full Text] [Related]
3. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Charni N; Juillet F; Garnero P Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703 [TBL] [Abstract][Full Text] [Related]
4. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430 [TBL] [Abstract][Full Text] [Related]
5. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis. Oestergaard S; Chouinard L; Doyle N; Smith SY; Tankó LB; Qvist P Arthritis Rheum; 2006 Sep; 54(9):2886-90. PubMed ID: 16947421 [TBL] [Abstract][Full Text] [Related]
6. Skeletal unloading induces a full-thickness patellar cartilage defect with increase of urinary collagen II CTx degradation marker in growing rats. Tomiya M; Fujikawa K; Ichimura S; Kikuchi T; Yoshihara Y; Nemoto K Bone; 2009 Feb; 44(2):295-305. PubMed ID: 19000792 [TBL] [Abstract][Full Text] [Related]
7. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis. Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: experiment with rats]. Yao ZQ; Zhao JX; Li R; Li ZG Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3055-8. PubMed ID: 17288836 [TBL] [Abstract][Full Text] [Related]
9. Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis. Sandya S; Sudhakaran PR Exp Biol Med (Maywood); 2007 May; 232(5):629-37. PubMed ID: 17463159 [TBL] [Abstract][Full Text] [Related]
11. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
13. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis. Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085 [TBL] [Abstract][Full Text] [Related]
14. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Oestergaard S; Sondergaard BC; Hoegh-Andersen P; Henriksen K; Qvist P; Christiansen C; Tankó LB; Karsdal MA Arthritis Rheum; 2006 Aug; 54(8):2441-51. PubMed ID: 16871544 [TBL] [Abstract][Full Text] [Related]
15. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331 [TBL] [Abstract][Full Text] [Related]
17. Effects and mechanisms of total glucosides of paeony on joint damage in rat collagen-induced arthritis. Zhu L; Wei W; Zheng YQ; Jia XY Inflamm Res; 2005 May; 54(5):211-20. PubMed ID: 15953993 [TBL] [Abstract][Full Text] [Related]
18. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats. Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636 [TBL] [Abstract][Full Text] [Related]
20. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Kojima T; Mwale F; Yasuda T; Girard C; Poole AR; Laverty S Arthritis Rheum; 2001 Jan; 44(1):120-7. PubMed ID: 11212149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]